www.hivandhepatitis.com

Skip to content

IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio

Details: Category: Gonorrhea; Published on Tuesday, 01 November 2016 00:00; Written by Liz Highleyman

Routine surveillance in southern Ohio has detected a steep increase in gonorrhea showing resistance to ciprofloxacin or reduced susceptibility to azithromycin, according to a presentation at IDWeek last week in New Orleans. Azithromycin is one of the 2 drugs in the sole recommended gonorrhea treatment regimen in the U.S., but no resistance to ceftriaxone, the other drug in that regimen, was seen.

alt

Sexually Transmitted Disease Rates Hit New Highs, CDC Report Says

Details: Category: Other STDs; Published on Wednesday, 19 October 2016 00:00; Written by Liz Highleyman

Cases of chlamydia, gonorrhea, and syphilis are at their highest level ever -- exceeding last year's record levels -- even as STD prevention, testing, and treatment services have eroded, according to the latest Sexually Transmitted Disease Surveillance report, released this week by the Centers for Disease Control and Prevention (CDC). Young people and gay and bisexual men are particularly heavily impacted, and transmission of syphilis from pregnant women to their babies is a growing concern.

alt

STD Prevention Conference: Drug-resistant Gonorrhea Rates Plummet in U.S.

Details: Category: Gonorrhea; Published on Thursday, 19 June 2014 00:00; Written by Gus Cairns

Preliminary results announced at the U.S. 2014 STD Prevention Conference last week in Atlanta have shown that the proportion of cases of gonorrhea that are drug-resistant has fallen since 2011, with a sharp decline between 2012 and 2013. The fall is particularly marked among gay and other men who have sex with men (MSM), who had had the highest rates of drug-resistant gonorrhea.
alt

STD 2016: Syphilis Rates Are Rising Among Gay Men, CDC Data Show

Details: Category: Syphilis; Published on Tuesday, 27 September 2016 00:00; Written by Liz Highleyman

New state-level data reveal that syphilis cases continue to rise among gay and bisexual men, with men in the south having the highest rates, according to a presentation at the 2016 STD Prevention Conference last week in Atlanta. A related study found that half of gay and bisexual men in 20 cities were screened for syphilis during the past year, with 11% testing positive.

alt

Coalition Calls for Wider Use of Sexual Health Care Services in U.S.

Details: Category: Other STDs; Published on Monday, 12 May 2014 00:00; Written by National Coalition for Sexual Health

The National Coalition for Sexual Health -- comprised of nearly 40 organizations focused on HIV, sexually transmitted diseases, and other aspects of sexual health -- last week issued a call-to-action and announced new resources aimed at improving access to and acceptance of sexual health services, which are now more readily available under the Affordable Care Act (ACA).

STD 2016: Growing Threat of Antibiotic-Resistant Gonorrhea in the U.S. and Worldwide

Details: Category: Gonorrhea; Published on Wednesday, 21 September 2016 00:00; Written by Liz Highleyman

Public health officials in Hawaii have identified the first cluster of gonorrhea cases with reduced susceptibility to both drugs in the current recommended regimen, according to a report at the 2016 STD Prevention Conference taking place this week in Atlanta. While all 7 patients were successfully treated, this cluster underscores the need for new therapies, one of which was presented at the conference.

alt

Helicase Inhibitor Pritelivir Shows Promise Against Genital Herpes

Details: Category: Herpes; Published on Friday, 31 January 2014 00:00; Written by Liz Highleyman

Pritelivir, a helicase inhibitor that interferes with viral replication, reduced the rate of herpes simplex virus type 2 (HSV-2) genital shedding, which has the potential to reduce sexual transmission, according to a small study described in the January 16, 2014, New England Journal of Medicine.

alt

ASM Microbe 2016: Novel Immune Therapy GEN-003 Improves Genital Herpes

Details: Category: Herpes; Published on Thursday, 23 June 2016 00:00; Written by Liz Highleyman

GEN-003, a therapeutic vaccine containing recombinant herpes simplex virus (HSV) antigens, showed significant antiviral activity lasting up to a year and reduced the number of genital herpes lesions and days with recurrences, researchers reported this week at the ASM Microbe 2016 meeting in Boston.

alt

CDC STD Report Shows Rise in Gonorhea, Syphilis

Details: Category: Other STDs; Published on Friday, 10 January 2014 00:00; Written by Liz Highleyman

The U.S. Centers for Disease Control and Prevention (CDC) this week released its annual sexually transmitted disease (STD) surveillance report on chlamydia, gonorrhea, and syphilis, showing that the latter two infections have increased by 4% and 11%, respectively, with the rise in syphilis occurring primarily among gay and bisexual men.

alt

CDC Releases Updated Sexually Transmitted Disease Treatment Guidelines

Details: Category: Human Papillomavirus (HPV); Published on Thursday, 16 July 2015 00:00; Written by HIVandHepatitis.com

In June the U.S. Centers for Disease Control and Prevention (CDC) published updates guidelines for the treatment of sexually transmitted diseases (STDs). The guidelines include information on more than 2 dozen different sexually transmitted infections, as well as STD complications such as pelvic inflammatory disease and cervical and anal cancer.

ICAAC 2013: Novel Therapeutic Vaccine Reduces Genital Herpes Shedding

Details: Category: Herpes; Published on Tuesday, 17 September 2013 00:00; Written by Genocea Biosciences

An experimental immune-modulating vaccine significantly reduced shedding of herpes simplex virus type 2 (HSV-2) in people with recurrent genital herpes, according to a late-breaker presentation at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) this week in Denver. The vaccine appeared safe and well-tolerated.

alt

April Is Sexually Transmitted Disease Awareness Month

Details: Category: Other STDs; Published on Friday, 17 April 2015 00:00; Written by HIVandHepatitis.com

April is STD Awareness Month in the U.S., an opportunity to promote education and raise awareness about sexually transmitted infections and to encourage people to get tested. Half of the estimated 20 million STDs that occur in the U.S. each year are among young people, and this year's STD Awareness Month effort focuses on this population.

alt

New Antibiotic Regimens Shown Effective Against Drug-resistant Gonorrhea

Details: Category: Other STDs; Published on Friday, 19 July 2013 00:00; Written by Liz Highleyman

A pair of antibiotic regimens using the existing drugs gentamicin or gemifloxacin plus azithromycin work against resistant gonorrhea, but come with side effects, CDC and NIH researchers reported at the 20th Meeting of the International Society for Sexually Transmitted Diseases Research this week in Vienna.

alt

Latest CDC Sexually Transmitted Disease Report Shows Gonorrhea Stable, Syphilis Rising

Details: Category: Other STDs; Published on Wednesday, 17 December 2014 00:00; Written by CDC

The number of cases of chlamydia declined slightly from 2012 to 2013, while cases of gonorrhea remained nearly stable and syphilis increased by 10%, according the latest Centers for Disease Control and Prevention (CDC) annual STD surveillance report. These broad trends, however, mask some notable differences between population groups, including high STD rates among gay men.

alt

Drug Resistant Gonorrhea Makes its Way into North America

Details: Category: Other STDs; Published on Wednesday, 20 February 2013 00:00; Written by Cyd Nova

The first documented failure of oral treatment for gonorrhea in North America has been reported in Toronto. The article, Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefexime in Toronto, Canada, published in the January 9, 2013, Journal of the American Medical Association, provides support for growing concern surrounding the second most prevalent bacterial sexually transmitted infection in the world.
alt

IDWeek 2014: Syphilis Cases Increase Among Men with HIV Despite Risk Reduction Counseling

Details: Category: Syphilis; Published on Tuesday, 28 October 2014 00:00; Written by Theo Smart

There has been a substantial increase in the number of syphilis cases among men living with HIV -- particularly men who have sex with men (MSM) -- despite systematic risk reduction counseling in this population since 2008, according to a study conducted at a clinic in rural Pennsylvania presented at IDWeek 2014 earlier this month.

alt

CDC Recommendation: Dual Treatment to Curb Tide of Drug-Resistant Gonorrhea

Details: Category: Other STDs; Published on Tuesday, 14 August 2012 00:00; Written by Cyd Nova

Increasing fears about the emergence of antibiotic resistant gonorrhea in the U.S. have prompted new treatment and surveillance recommendations from the Centers for Disease Control and Prevention (CDC). Gail Bolan, director of the agency's Division of STD Prevention, called the move "a critical pre-emptive strike to preserve the last effective treatment option." alt

Chlamydia Widespread in U.S., Task Force Recommends Screening for Young Women

Details: Category: Other STDs; Published on Friday, 03 October 2014 00:00; Written by HIVandHepatitis.com

Chlamydia -- the most commonly reported sexually transmitted infection in the U.S. -- had an overall prevalence of 1.7% among people age 14 to 39 in the latest NHANES survey, but this rose to 4.7% among sexually active young women. Updated guidelines from the U.S. Preventive Services Task Force recommend regular chlamydia and gonorrhea screening for sexually active women age 24 and younger, and for older women at increased risk for infection, but state that there is not enough evidence to make a similar recommendation for men.

alt

WHO Warns of Global Threat of Drug-resistant Gonorrhea

Details: Category: Other STDs; Published on Friday, 08 June 2012 00:00; Written by Liz Highleyman

Multidrug-resistant gonorrhea is a growing concern worldwide and millions of people may be at risk of running out of treatment options unless urgent action is taken, according to an alert issued this week by the World Health Organization (WHO). alt

ICAAC 2014: Delafloxacin Shows Promise as a Single-dose Treatment for Gonorrhea

Details: Category: Gonorrhea; Published on Friday, 12 September 2014 00:00; Written by Liz Highleyman

A new antibiotic, delafloxacin, demonstrated potent activity against gonorrhea -- including drug-resistant strains -- in a laboratory study, and its pharmacokinetics suggest that single-dose oral treatment will be feasible, according to research presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy this week in Washington, DC.

alt

Researchers Report Setbacks on Herpes Simplex Vaccine and Treatment

Details: Category: Herpes; Published on Friday, 24 February 2012 00:00; Written by Liz Highleyman

An experimental herpes simplex virus (HSV) vaccine partially protected women against infection with HSV type 1 but not type 2, according to a recent report in the New England Journal of Medicine. Another recent study found that antiviral treatment with acyclovir (Zovirax) or valacyclovir (Valtrex) did not prevent periodic HSV-2 reactivation and viral shedding. alt

Subcategories

Page 1 of 2

Start
Prev
1
2
Next
End

	The Liver Meeting (AASLD 2017) October 20-24, 2017, Washington, DC
	6th European AIDS Conference (EACS 2017) October 20-27, 2017, Milan
	9th IAS Conference on HIV Science (IAS 2017) July 23-26, 2017, Paris
	2017 Harm Reduction International Conference May 14-17, 2017, Montreal
	2017 Pediatric Academic Societies Meeting May 6-9, 2017, San Francisco
	2017 EASL International Liver Congress April 19-23, 2017, Amsterdam
	2017 Conference on Retroviruses and Opportunistic Infections (CROI 2017) February 13-16, 2017, Seattle
	The Liver Meeting (AASLD 2016) November 11-15, 2016, Boston
	IDWeek 2016 October 26-30, 2016, New Orleans
	HIV Drug Therapy 2016 October 23-26, 2016, Glasgow
	HIV Research for Prevention (HIVR4P 2016) October 17-21, 2016, Chicago
	5th International Symposium on Hepatitis Care in Substance Users (INHSU 2016) Sept 7-9, 2016, Oslo
	21st International AIDS Conference (AIDS 2016) July 18-22, 2016, Durban
	ASM Microbe 2016/ICAAC 2016 June 16-20, 2016, Boston
	2016 EASL International Liver Congress April 13-17, 2016, Barcelona
	2016 Conference on Retroviruses and Opportunistic Infections (CROI 2016) February 22-25, 2016, Boston
	2015 National HIV Prevention Conference (NHPC 2015) December 6-9, 2015, Atlanta
	46th Union World Conference on Lung Health December 2-6, 2015, Cape Town
	The Liver Meeting (AASLD 2015) November 13-17, 2015, San Francisco
	15th European AIDS Conference (EACS 2015) October 21-24, 2015, Barcelona
	24th International Harm Reduction Conference (IHRC 2015) October 18-21, 2015, Kuala Lumpur
	IDWeek 2015 October 7-11, 2015, San Diego
	4th International Symposium on Hepatitis Care in Substance Users (INHSU 2015) October 7-9, 2015, Sydney
	55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2015) September 17-21, 2015, San Diego
	8th International AIDS Society Conference on HIV Pathogenesis, Treatment & Prevention (IAS 2015) July 19-22, 2015, Vancouver
	Digestive Disease Week 2015 May 16-19, 2015, Washington, DC
	50th International Liver Congress (EASL 2015) April 22-26, 2015, Vienna
	21st Annual Meeting of the British HIV Association (BHIVA) April 21-24, 2015, Brighton
	2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015) February 23-26, 2015, Seattle